Physician

Ali Marhaba, MD

According to 2025 Medicare claims, Ali Marhaba, MD (NPI: 1104827138) practices gastroenterology in the Binghamton, NY market, with the plurality of this provider's patient population coming from Broome, NY. This provider's primary affiliated billing organization is UNITED HEALTH SERVICES HOSPITALS, INC. (NPI: 1962463851; TIN: 161165049) and primary practice location at 13903-1617.

Marhaba's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 666 traditional Medicare patients, billed 1,586 HCPCS/CPT codes, and received $115,151 in Medicare payments. The top billing code was 45385 (Removal of polyps or growths of large bowel using an endoscope with mechanical snare). Part D data shows 1,833 prescription claims across 470 beneficiaries totaling $1,463,786 in drug costs, led by Stelara (Ustekinumab). 2020 DME data shows 12 claims. Open Payments data shows 11 records totaling $216. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $547,403 to $1,463,786. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	874	1,624	$172,698
2016	869	1,477	$157,144
2017	791	1,724	$135,121
2018	767	1,719	$143,453
2019	737	1,748	$140,261
2020	585	1,479	$111,971
2021	708	1,656	$132,427
2022	652	1,517	$123,052
2023	629	1,433	$118,129
2024	666	1,586	$115,151

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	432	1,919	$547,403
2016	430	1,816	$257,601
2017	449	2,069	$604,078
2018	470	2,117	$634,590
2019	472	1,931	$704,716
2020	487	2,058	$812,376
2021	539	2,171	$647,011
2022	575	2,216	$953,008
2023	509	1,801	$1,644,578
2024	470	1,833	$1,463,786

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	26	$3,331
2017	N/R	36	$3,108
2018	N/R	41	$2,499
2019	N/R	47	$2,970
2020	N/R	12	$89
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
45385	Removal of polyps or growths of large bowel using an endoscope with mechanical snare	170	170	$199
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	115	145	$69
43239	Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope	181	184	$66
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	105	122	$13
G0500	Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito	388	407	$4

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Stelara	Ustekinumab	33	1,624	$839,729
Humira(Cf) Pen	Adalimumab	26	728	$193,891
Creon	Lipase/Protease/Amylase	50	1,814	$67,859
Xifaxan	Rifaximin	17	510	$54,294
Linzess	Linaclotide	66	2,760	$51,236

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	11	$216	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ali Marhaba, MD?

Tedicare shows public-source Medicare data for Ali Marhaba, MD (NPI 1104827138), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ali Marhaba, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Ali Marhaba, MD?

Ali Marhaba, MD is linked to UNITED HEALTH SERVICES HOSPITALS, INC. (billing NPI 1962463851) in the available physician profile data.

Does Ali Marhaba, MD have Open Payments data?

Ali Marhaba, MD has 11 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.